On December 26, 2023, Shanghai Vcanbio Jisheng Cell Technology Co., Ltd. closed the transaction. The company's registered capital increased by CNY 20 million post-completion of the transaction.
Vcanbio Cell & Gene Engineering Corp., Ltd
Equities
600645
CNE000000545
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17.69 CNY | -2.96% | -4.02% | -12.73% |
1st Jan change | Capi. | |
---|---|---|
-12.73% | 1.16B | |
-5.86% | 12.09B | |
-4.87% | 8.21B | |
+5.47% | 5.74B | |
+27.42% | 5.64B | |
-9.89% | 4.16B | |
-58.99% | 2.88B | |
+8.97% | 2.69B | |
-5.19% | 2.33B | |
+21.58% | 2.17B |
- Stock Market
- Equities
- 600645 Stock
- News Vcanbio Cell & Gene Engineering Corp., Ltd
- Shanghai Vcanbio Jisheng Cell Technology Co., Ltd. announced that it has received CNY 20 million in funding from Vcanbio Cell & Gene Engineering Corp., Ltd